← All organizations

Jordan Collaborating Cardiology Group

Academic/Hospital

Also known as: Jordan Collaborating Cardiology Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 20, 2017

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

lansoprazole

Phase 3 (1 own, 0 via acquisition)

colchicine

Other trials (1 own, 0 via acquisition)

rabeprazole

Indications

Studied for

Recent trials (4)

NCT03273634Lead sponsorPhase 4May 20, 2017
NCT03015831Lead sponsorPhase 3Mar 1, 2017
NCT02826408Lead sponsorN/AOct 1, 2016
NCT03021343Lead sponsorPhase 3Oct 1, 2012

Details

Last known activity: May 20, 2017